The relationship between serum prolactin level and sexual functioning among male outpatients with schizophrenia or schizoaffective disorder: A randomized double-blind trial of risperidone vs. quetiapine

Journal of Sex and Marital Therapy

Volumn 33, Issue 3, 2007, Pages 203-216

  Nakonezny, Paul A ^a   Byerly, Matthew J ^a   Rush, A John ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROLACTIN; QUETIAPINE; RISPERIDONE;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DOUBLE BLIND PROCEDURE; DRUG DOSE TITRATION; HUMAN; LIBIDO; MALE; MALE SEXUAL DYSFUNCTION; NEGATIVE SYNDROME; OUTPATIENT; PENIS ERECTION; POSITIVE SYNDROME; PROLACTIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SCORING SYSTEM; SEXUAL AROUSAL; SEXUAL FUNCTION; SIDE EFFECT;

ADULT; ANTIPSYCHOTIC AGENTS; DIBENZOTHIAZEPINES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; HUMANS; MALE; MIDDLE AGED; ORGASM; OUTPATIENTS; PROLACTIN; RISPERIDONE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEVERITY OF ILLNESS INDEX; SEXUAL DYSFUNCTION, PHYSIOLOGICAL;

EID: 34047221707     PISSN: 0092623X     EISSN: 15210715     Source Type: Journal    
DOI: 10.1080/00926230701267829     Document Type: Article

References (19)

1. Arnt, J., & Skarsfeldt, T. (1998). Do novel anti-psychotics have similar pharmacological characteristics? A review of the evidence. Neuropsychopharmacology, 18, 63-101.
2. Burke, M. A., McEvoy, J. P., & Ritchie, J. C. (1994). A pilot study of a structured interview addressing sexual function in men with schizophrenia. Biological Psychiatry, 35, 32-35.
3. Byerly, M., Nakonezny, P., Bugno, R., Boles, J., & Rush, A. J. (May 23, 2006). A randomized, double-blind pilot trial of switching to quetiapine vs. risperidone continuation in outpatients with risperidone-associated sexual dysfunction. Paper presented at the American Psychiatric Association's 159th Annual Meeting, Toronto, Ontario, Canada.
4. Byerly, M. J., Nakonezny, P. A., Fisher, R., Magouirk, B., & Rush, A. J. (2006). An empirical evaluation of the Arizona sexual experience scale and a simple one-item screening test for assessing anti-psychotic-related sexual dysfunction in outpatients with schizophrenia and schizoaffective disorder. Schizophrenia Research, 81, 311-316.
5. Cutler, A. J. (2003). Sexual dysfunction and antipsychotic treatment. Psychoneuroendocrinology, 28 suppl, 69-82.
6. Ghadirian, A. M., Chouinard, G., & Annable, L. (1982). Sexual dysfunction and plasma prolactin levels in neuroleptic-treated schizophrenic outpatients. Journal of Nervous and Mental Disease, 170, 463-467.
7. Gitlin, M. J. (1994). Psychotropic medications and their effects on sexual function: Diagnosis, biology, and treatment approaches. Journal of Clinical Psychiatry, 55, 406-413.
8. Halbreich, U., Kinon, B. J., Gilmore, J. A., & Kahn, L. S. (2003). Elevated prolactin levels in patients with schizophrenia: Mechanisms and related adverse effects. Psychoneuroendocrinology, 28 suppl, 53-67.
9. Kay, S. R., Fiszbein, A., & Opler, L. A. (1987). The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin, 13, 261-276.
10. Keller, R., & Mongini, F. (2002). Switch to quetiapine in antipsychotic agent-related hyperprolactinemia. Neurological Science 23, 233-235.
11. Kelly, D. L., & Conley, R. R. (2004). Sexuality and schizophrenia: A review. Schizophrenia Bulletin, 30, 767-779.
12. Kim, K. S., Pae, C. U., Chae, J. H., Bahk, W. M., Jun, T. Y., Kim, D. J., & Dickson, R. A. (2002). Effects of olanzapine on prolactin levels of female patients with schizophrenia treated with risperidone. Journal of Clinical Psychiatry, 63, 408-413.
13. Kleinberg, D. L., Davis, J. M., de Coster, R., Van Baelen, B., & Brecher, M. (1999). Prolactin levels and adverse events in patients treated with risperidone. Journal of Clinical Psychopharmacology, 19, 57-61.
14. Knegtering, H., van der Moolen, A. E., Castelein, S., Kluiter, H., & van den Bosch, R. J. (2003). What are the effects of anti-psychotics on sexual dysfunctions and endocrine functioning? Psychoneuroendocrinology, 28 suppl, 109-123.
15. Knegtering, R., Castelein, S., Bous, H., Van Der Linde, J., Bruggeman, R., Kluiter, H., & van den Bosch, R. J. (2004). A randomized open-label study of the impact of quetiapine versus risperidone on sexual functioning. Journal of Clinical Psychopharmacology, 24, 56-61.
16. Kotin, J., Wilbert, D. E., Verburg, D., & Soldinger, S. M. (1976). Thioridazine and sexual dysfunction. American Journal of Psychiatry, 133, 82-85.
17. McGahuey, C. A., Gelenberg, A. J., Laukes, C. A., Moreno, F. A., Delgado, P. L., McKnight, K. M., & Manber, R. (2000). The Arizona Sexual Experience Scale (ASEX): Reliability and validity. Journal of Sex and Marital Therapy, 26, 25-40.
18. Meaney, A. M., & O'Keane, V. (2002). Prolactin and schizophrenia: Clinical consequences of hyperprolactinaemia. Life Sciences, 71, 979-992.
19. Nakajima, M., Terao, T., Iwata, N., & Nakamura, J. (2005). Switching female schizophrenic patients to quetiapine from conventional antipsychotic drugs: Effects on hyperprolactinemia. Pharmacopsychiatry, 38, 17-19.